News
After a 20% stock plunge, Denmark's prized drugmaker triggers fears over jobs, confidence, and consumer spending.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback